Cited by 87Substance Abuse Treatment and OutcomesPharmaceutical Practices and Patient OutcomesAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Long-term benzodiazepine users 3 years after participation in a discontinuation program

Karl Rickels, WARREN G. CASE, Edward Ernest Schweizer, Francisco García España, R Fridman·1991·American Journal of Psychiatry

Abstract

OBJECTIVE: Clinical status and use of benzodiazepines and other psychotropic drugs at follow-up were assessed in patients who had been chronically dependent on benzodiazepines and had been referred for participation in a discontinuation study. METHOD: Of 123 benzodiazepine-dependent patients screened for entry into a tapered discontinuation program, 48 had completed the program, 38 had not, and 37 had not undergone drug tapering. Follow-up information was obtained through a structured telephone interview and a mail questionnaire that included a global severity scale assessing anxiety and depression and the Hopkins Symptom Checklist. The time to follow-up was 2.7-5.0 years, and the mean +/- SD interval between screening and follow-up was 2.9 +/- 0.9 years. RESULTS: Outcome at follow-up significantly favored the patients who had completed the discontinuation program; 73% were not using benzodiazepines, compared to 39% in the unsuccessful taper group and 14% in the no-taper group. Moderate or marked anxiety was still reported by 35% of the patients who were taking benzodiazepines and 25% of those who were not. At follow-up, 22% of the patients were being treated with nonbenzodiazepine psychotropic agents, primarily antidepressants. CONCLUSIONS: The high percentage of patients who were benzodiazepine-free at follow-up and the continued anxiety and depression present in many patients suggest that some patients may have been taking benzodiazepines because of chronic or recurrent anxiety or depression, not physical dependence.

Integrity signals

Registry

Crossref · 10.1176/ajp.148.6.757

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In Rickels 1991, anxiety and depression levels were significantly lower for patients who had discontinued benzodiazepines versus those taking benzodiazepines.

    “Anxiety and depression levels were significantly lower for patients who had d/c BZD versus those taking BZD”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rickels, K., CASE, W. G., Schweizer, E. E., España, F. G., & Fridman, R.
Affiliations
University of Pennsylvania (US)
Venue
American Journal of Psychiatry
Published
1991-06-01
Volume
148
Issue
6
Pages
757-761
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2406339002
Cited by
87
References
15
Citations by year
2026: 2 · 2025: 2 · 2024: 4 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 2 · 2016: 2 · 2015: 1 · 2014: 2 · 2013: 2 · 2012: 1
FWCI
3.21
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (1f31mh009857-01)
  • National Institute of Mental Health (MH-09857)
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
benzodiazepine dependence, benzodiazepine tapering, long-term follow-up, anxiety, depression, psychotropic drug use, antidepressants
MeSH terms
Anxiety Disorders, Benzodiazepines, Chronic Disease, Depressive Disorder, Diagnosis, Differential, Female, Follow-Up Studies, Humans, Male, Middle Aged, Outcome and Process Assessment, Health Care, Psychiatric Status Rating Scales, Recurrence, Regression Analysis, Substance Withdrawal Syndrome, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review